Cancer cells hijack a fatty acid to escape immune attack in liver metastases
Collaboration aims to develop new class of medicines for in vivo CAR-T
Data validates new method for single-cell transcriptomic tumour profiling from clinical pathology samples
White paper looks at early clinical development of B-cell depletion therapies in autoimmune disease
Study identifies which patients benefit most from new schizophrenia drug
Mechanism behind overactive immune cells revealed
Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation
World’s first gene-editing therapy for hyperlipidemia
Positive results for Lilly obesity drug
“Foundational moment for in vivo cell therapy”
Cooperative motor proteins kill cancer cells when dual-inhibited
SanegeneBio announces collaboration with Lilly